Solventum Corporation - SIC # 8092 - KIDNEY DIALYSIS CENTERS

Ticker Exchange SIC # Website Latest Ticker
SOLV New York 8092 www.solventum.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Solventum Corporation

Solventum to Report First Quarter Fiscal 2025 Earnings on May 8, 2025 - Apr 17th, 2025 8:05 pm
Solventum partners with SprintRay to disrupt the digital dentistry market with high-quality, permanent same-day restorations - Mar 25th, 2025 10:00 pm
Solventum to Present Value Creation Formula and Long-Range Plan at 2025 Investor Day - Mar 20th, 2025 1:00 pm
Alger Russell Innovation Index Updates for First Quarter 2025 - Mar 17th, 2025 9:28 pm
Solventum Launches Attest™ eBowie-Dick Test System Revolutionizing Sterilization Assurance - Mar 12th, 2025 12:12 pm
Solventum forecasts annual profit above estimates on strong surgical product sales - Feb 27th, 2025 10:08 pm
Solventum Reports Fourth Quarter 2024 Financial Results and Introduces 2025 Full-Year Guidance - Feb 27th, 2025 9:05 pm
Nelson Peltz’s Trian Pushes Solventum to Further Simplify Business - Feb 26th, 2025 11:27 pm
Solventum to Host Investor Day on Thursday, March 20, 2025, in New York City - Feb 26th, 2025 9:15 pm
Healthcare sector leading markets in 2025: What to know - Feb 26th, 2025 9:11 pm
Trian Comments on Solventum’s Sale of its Purification & Filtration Business - Feb 26th, 2025 7:50 pm
Thermo Fisher Strikes Deal for Solventum’s Filtration Unit - Feb 25th, 2025 2:10 pm
Solventum Announces Sale of its Purification & Filtration Business to Thermo Fisher Scientific Inc. for $4.1B - Feb 25th, 2025 1:25 pm
Ampersand Biomedicines Appoints Elizabeth Mily to Board of Directors - Feb 11th, 2025 1:00 pm
Solventum Fluency for Imaging clinches top spot again: Ranked #1 Best in KLAS for Speech Recognition: Front-end Imaging - Feb 5th, 2025 3:00 pm
Solventum to Report Fourth Quarter and Full Year Fiscal 2024 Earnings on February 27, 2025 - Jan 30th, 2025 9:05 pm
Solventum Corporation (NYSE:SOLV) is largely controlled by institutional shareholders who own 63% of the company - Jan 30th, 2025 3:38 pm
Trian Issues Open Letter to Solventum Shareholders - Jan 8th, 2025 6:01 pm
The T1D Fund Appoints Industry Veteran Elizabeth Mily as CEO to Accelerate Development of Type 1 Diabetes Cures Through Impact Investing - Jan 8th, 2025 11:30 am
Is Solventum Corporation (NYSE:SOLV) Trading At A 31% Discount? - Jan 3rd, 2025 3:03 pm